Find a Tender
complete
Official procurement procedure
Erythropoietin Stimulating Agents & IV Iron
Pharmaceutical products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Velindre NHS Trust, NHS Shared Services Partnership — Procurement Services (on behalf of All Wales Health Boards and Trusts): "Erythropoietin Stimulating Agents & IV Iron". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | Velindre NHS Trust, NHS Shared Services Partnership — Procurement Services (on behalf of All Wales Health Boards and Trusts) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: Velindre NHS Trust, NHS Shared Services Partnership — Procurement Services (on behalf of All Wales Health Boards and Trusts)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for Velindre NHS Trust, NHS Shared Services Partnership — Procurement Services (on behalf of All Wales Health Boards and Trusts). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
10.5Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 35 active published awards; 34 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Procedure methodNot published | Procurement categoryNot published | |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published1 Sept 2023, 11:12 BST | Last source update1 Sept 2023, 11:12 BST | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area | ||
OCIDocds-h6vhtk-03bf22 | ||
What is being bought
Erythropoietin Stimulating Agents & IV Iron
What changed
From the official release history
- tender value changed
1 Sept 2023, 11:12 BST - Status changed to complete
1 Sept 2023, 11:12 BST - Official notice release published
1 Sept 2023, 11:12 BST - Submission deadline changed to published date
1 Sept 2023, 11:12 BST - Published value updated to £15,282,400
17 Apr 2023, 12:21 BST - Status changed to active
17 Apr 2023, 12:21 BST - Official notice release published
17 Apr 2023, 12:21 BST - Submission deadline changed to 23 May 2023, 10:00 BST
17 Apr 2023, 12:21 BST - Buyer information updated
17 Apr 2023, 12:21 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedErythropoietin Stimulating Agents & IV IronContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
1 Sept 2023, 11:12 BST - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 31 Aug 2023, 00:00 BST · £1,884,620 - Contract active
Signed 31 Aug 2023, 00:00 BST · £1,618,961 - Contract active
Signed 31 Aug 2023, 00:00 BST · £3,981,265 - Contract active
Signed 31 Aug 2023, 00:00 BST · £3,023,475 - Contract active
Signed 31 Aug 2023, 00:00 BST · £9,583,941
Commercial outcome and competition
Awards Amgen Limited Not published · Not published · active Janssen Limited Not published · Not published · active Pharmacosmos UK Ltd Not published · Not published · active Roche Products Ltd Not published · Not published · active Vifor Pharma UK Ltd Not published · Not published · active |
Contracts Erythropoietin Stimulating Agents & IV Iron £1,884,620 · signed 31 Aug 2023, 00:00 BST · active Erythropoietin Stimulating Agents & IV Iron £1,618,961 · signed 31 Aug 2023, 00:00 BST · active Erythropoietin Stimulating Agents & IV Iron £3,981,265 · signed 31 Aug 2023, 00:00 BST · active Erythropoietin Stimulating Agents & IV Iron £3,023,475 · signed 31 Aug 2023, 00:00 BST · active Erythropoietin Stimulating Agents & IV Iron £9,583,941 · signed 31 Aug 2023, 00:00 BST · active |
Bid statistics bids: 5 (lot 1) bids: 5 (lot 1) bids: 5 (lot 1) bids: 5 (lot 1) bids: 5 (lot 1) |
Buyer and organisations in this procedure
Velindre NHS Trust, NHS Shared Services Partnership — Procurement Services (on behalf of All Wales Health Boards and Trusts)
Contracting authority GB-FTS-1379Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published